메뉴 건너뛰기




Volumn 94, Issue 4, 2013, Pages 449-451

Experience of a vasopressin receptor antagonist, tolvaptan, under the unique indication in Japanese heart failure patients

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; FUROSEMIDE; PLACEBO; SODIUM; TOLVAPTAN;

EID: 84884501178     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.147     Document Type: Review
Times cited : (23)

References (5)
  • 1
    • 84974539516 scopus 로고    scopus 로고
    • Disorders of water homeostasis
    • ed. Schrier, R.W., Lippincott Williams & Wilkins
    • Berl, T. & Schrier, R.W. Disorders of water homeostasis. In Renal and Electrolyte Disorders 7th edn. (ed. Schrier, R.W.) 1-44 (Lippincott Williams & Wilkins, 2010).
    • (2010) Renal and Electrolyte Disorders 7th Edn , pp. 1-44
    • Berl, T.1    Schrier, R.W.2
  • 2
    • 79952768369 scopus 로고    scopus 로고
    • Tolvaptan for the treatment of heart failure: A review of the literature
    • Ambrosy, A., Goldsmith, S.R. & Gheorghiade, M. Tolvaptan for the treatment of heart failure: a review of the literature. Expert Opin. Pharmacother. 12, 961-976 (2011).
    • (2011) Expert Opin. Pharmacother. , vol.12 , pp. 961-976
    • Ambrosy, A.1    Goldsmith, S.R.2    Gheorghiade, M.3
  • 3
    • 84878580083 scopus 로고    scopus 로고
    • Clinical course of patients with hyponatremia and decompensated systolic heart failure and the efect of vasopressin receptor antagonism with tolvaptan
    • Everest Investigators.
    • Hauptman, P.J. et al.; Everest Investigators. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the efect of vasopressin receptor antagonism with tolvaptan. J. Card. Fail. 19, 390-397 (2013).
    • (2013) J. Card. Fail. , vol.19 , pp. 390-397
    • Hauptman, P.J.1
  • 4
    • 83655212353 scopus 로고    scopus 로고
    • Efcacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: A phase III, randomized, double-blind, placebo-controlled study (QUEST study)
    • Matsuzaki, M., Hori, M., Izumi, T. & Fukunami, M.; Tolvaptan Investigators. Efcacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study). Cardiovasc. Drugs Ther. 25 (suppl. 1), S33-S45 (2011).
    • (2011) Cardiovasc. Drugs Ther. , vol.25 , Issue.SUPPL. 1
    • Matsuzaki, M.1    Hori, M.2    Izumi, T.3    Fukunami, M.4
  • 5
    • 84873806179 scopus 로고    scopus 로고
    • Novel criteria of urine osmolality efectively predict response to tolvaptan in decompensated heart failure patients-association between non-responders and chronic kidney disease
    • Imamura, T. et al. Novel criteria of urine osmolality efectively predict response to tolvaptan in decompensated heart failure patients-association between non-responders and chronic kidney disease. Circ. J. 77, 397-404 (2013).
    • (2013) Circ. J. , vol.77 , pp. 397-404
    • Imamura, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.